Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval

Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval aliu Tue, 06/18/2024 - 09:39